Nordihydroguaiaretic acid (NDGA) blocks the differentiation of C2C12 myoblast cells

被引:9
|
作者
Ito, H [1 ]
Ueda, H [1 ]
Iwamoto, I [1 ]
Inaguma, Y [1 ]
Takizawa, T [1 ]
Asano, T [1 ]
Kato, K [1 ]
机构
[1] Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, Aichi 4800392, Japan
关键词
D O I
10.1002/jcp.20177
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Addition of nordihydroguaiaretic acid (NDGA) to the differentiation medium of C2C12 mouse myoblast cells caused severe inhibition of the formation of myotubes and suppressed differentiation-dependent elevation in the levels of the creatine kinase M isozyme (CKM). Under these conditions, NDGA did not cause significant increase of damaged cells, as detected by annexin-V-FITC assay, or induction of heat shock proteins, known to be a response against extracellular stress. The results suggest that NDGA itself is not toxic but can effectively blocks the differentiation-dependent increase of CKM during C2C12 differentiation. The levels of muscle specific bHLH proteins MyoD, Myf5, and myogenin were also decreased by addition of NDGA, indicating a block of the initial step of the myogenesis through downregulation of muscle specific genes. NDGA is known to be a lipoxygenase inhibitor but other examples, like MK-886 and CDC, did not exert the same effects on differentiation of muscle cells, indicating that mechanisms of NDGA action are independent of its influence on lipoxygenase. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:874 / 879
页数:6
相关论文
共 50 条
  • [21] Pb inhibited C2C12 myoblast differentiation by regulating HDAC2
    Gu, Xiaozhen
    Shen, Nan
    Huang, Chengqing
    Wang, Hui-Li
    TOXICOLOGY, 2023, 499
  • [22] Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
    Liang, Rui
    Dong, Wei
    Shen, Xiaopeng
    Peng, Xiaoping
    Aceves, Angie G.
    Liu, Yu
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2016, (113):
  • [23] Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency
    Lou, Wenjia
    Reynolds, Christian A.
    Li, Yiran
    Liu, Jenney
    Huttemann, Maik
    Schlame, Michael
    Stevenson, David
    Strathdee, Douglas
    Greenberg, Miriam L.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2018, 1863 (08): : 857 - 865
  • [24] On microRNA-214 suppressing osteogenic differentiation of C2C12 myoblast cells by targeting Osterix
    Gruenhagen, Johannes
    Ott, Claus-Eric
    BONE, 2013, 57 (01) : 325 - 327
  • [25] Myostatin promotes tenogenic differentiation of C2C12 myoblast cells through Smad3
    Uemura, Kazutaka
    Hayashi, Masanori
    Itsubo, Toshiro
    Oishi, Ayumu
    Iwakawa, Hiroko
    Komatsu, Masatoshi
    Uchiyama, Shigeharu
    Kato, Hiroyuki
    FEBS OPEN BIO, 2017, 7 (04): : 522 - 532
  • [26] MicroRNA-214 suppresses osteogenic differentiation of C2C12 myoblast cells by targeting Osterix
    Shi, Kaikai
    Lu, Jianlei
    Zhao, Yue
    Wang, Lintao
    Li, Ji
    Qi, Bing
    Li, Hongwei
    Ma, Changyan
    BONE, 2013, 55 (02) : 487 - 494
  • [27] The Differentiation of C2C12 Cells to Myotube by Paraquat
    Okabe, Masaaki
    Akiyama, Koichi
    Nishimoto, Sogo
    Sugahara, Takuya
    Kakinuma, Yoshimi
    ANIMAL CELL TECHNOLOGY: BASICS & APPLIED ASPECTS, 2010, 16 : 215 - 219
  • [28] Notch Pathway Activation Contributes to Inhibition of C2C12 Myoblast Differentiation by Ethanol
    Arya, Michelle A.
    Tai, Albert K.
    Wooten, Eric C.
    Parkin, Christopher D.
    Kudryavtseva, Elena
    Huggins, Gordon S.
    PLOS ONE, 2013, 8 (08):
  • [29] Effect of miR-143-3p on C2C12 myoblast differentiation
    Du, Jingjing
    Zhang, Yi
    Shen, Linyuan
    Luo, Jia
    Lei, Huaigang
    Zhang, Peiwen
    Pu, Qiang
    Liu, Yihui
    Shuai, Surong
    Li, Qiang
    Li, Xuewi
    Zhang, Shunhua
    Zhu, Li
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2016, 80 (04) : 706 - 711
  • [30] Lactoferrin promotes murine C2C12 myoblast proliferation and differentiation and myotube hypertrophy
    Kitakaze, Tomoya
    Oshimo, Meiku
    Kobayashi, Yasuyuki
    Ryu, Mizuyuki
    Suzuki, Yasushi A.
    Inui, Hiroshi
    Harada, Naoki
    Yamaji, Ryoichi
    MOLECULAR MEDICINE REPORTS, 2018, 17 (04) : 5912 - 5920